These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21645364)

  • 1. Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients.
    Bossù P; Salani F; Alberici A; Archetti S; Bellelli G; Galimberti D; Scarpini E; Spalletta G; Caltagirone C; Padovani A; Borroni B
    J Neuroinflammation; 2011 Jun; 8():65. PubMed ID: 21645364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations.
    Kocerha J; Kouri N; Baker M; Finch N; DeJesus-Hernandez M; Gonzalez J; Chidamparam K; Josephs KA; Boeve BF; Graff-Radford NR; Crook J; Dickson DW; Rademakers R
    BMC Genomics; 2011 Oct; 12():527. PubMed ID: 22032330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
    Alquezar C; Esteras N; Alzualde A; Moreno F; Ayuso MS; López de Munain A; Martín-Requero Á
    PLoS One; 2012; 7(5):e37057. PubMed ID: 22623979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration.
    Skoglund L; Ingvast S; Matsui T; Freeman SH; Frosch MP; Brundin R; Giedraitis V; Growdon JH; Hyman BT; Lannfelt L; Ingelsson M; Glaser A
    Dement Geriatr Cogn Disord; 2009; 28(5):471-5. PubMed ID: 19940479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanisms of progranulin-deficient FTLD.
    Ward ME; Miller BL
    J Mol Neurosci; 2011 Nov; 45(3):574-82. PubMed ID: 21892758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin: an emerging target for FTLD therapies.
    Gass J; Prudencio M; Stetler C; Petrucelli L
    Brain Res; 2012 Jun; 1462():118-28. PubMed ID: 22338605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel progranulin mutation detected in 2 patients with FTLD.
    Skoglund L; Matsui T; Freeman SH; Wallin A; Blom ES; Frosch MP; Growdon JH; Hyman BT; Lannfelt L; Ingelsson M; Glaser A
    Alzheimer Dis Assoc Disord; 2011; 25(2):173-8. PubMed ID: 20975516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
    Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
    Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration.
    Krüger J; Kaivorinne AL; Udd B; Majamaa K; Remes AM
    Eur J Neurol; 2009 Jan; 16(1):27-30. PubMed ID: 19049508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.
    Feng T; Mai S; Roscoe JM; Sheng RR; Ullah M; Zhang J; Katz II; Yu H; Xiong W; Hu F
    EMBO Rep; 2020 Oct; 21(10):e50219. PubMed ID: 32852886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study.
    Gilberti N; Turla M; Alberici A; Bertasi V; Civelli P; Archetti S; Padovani A; Borroni B
    Neurol Sci; 2012 Aug; 33(4):899-904. PubMed ID: 22127750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal processing of progranulin.
    Zhou X; Paushter DH; Feng T; Sun L; Reinheckel T; Hu F
    Mol Neurodegener; 2017 Aug; 12(1):62. PubMed ID: 28835281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers.
    Alquézar C; Esteras N; de la Encarnación A; Alzualde A; Moreno F; López de Munain A; Martín-Requero A
    Neurobiol Aging; 2014 Apr; 35(4):886-98. PubMed ID: 24139281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
    Gass J; Cannon A; Mackenzie IR; Boeve B; Baker M; Adamson J; Crook R; Melquist S; Kuntz K; Petersen R; Josephs K; Pickering-Brown SM; Graff-Radford N; Uitti R; Dickson D; Wszolek Z; Gonzalez J; Beach TG; Bigio E; Johnson N; Weintraub S; Mesulam M; White CL; Woodruff B; Caselli R; Hsiung GY; Feldman H; Knopman D; Hutton M; Rademakers R
    Hum Mol Genet; 2006 Oct; 15(20):2988-3001. PubMed ID: 16950801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features.
    Karch CM; Ezerskiy L; Redaelli V; Giovagnoli AR; Tiraboschi P; Pelliccioni G; Pelliccioni P; Kapetis D; D'Amato I; Piccoli E; Ferretti MG; Tagliavini F; Rossi G
    Neurobiol Aging; 2016 Feb; 38():215.e1-215.e12. PubMed ID: 26652843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
    Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
    Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.
    Chiang HH; Forsell C; Lilius L; Öijerstedt L; Thordardottir S; Shanmugarajan K; Westerlund M; Nennesmo I; Thonberg H; Graff C
    Eur J Hum Genet; 2013 Nov; 21(11):1260-5. PubMed ID: 23463024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.